Andrew B. McElroy

1.8k total citations
37 papers, 1.4k citations indexed

About

Andrew B. McElroy is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Andrew B. McElroy has authored 37 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Organic Chemistry, 13 papers in Molecular Biology and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Andrew B. McElroy's work include Neuropeptides and Animal Physiology (7 papers), Asymmetric Synthesis and Catalysis (6 papers) and Protease and Inhibitor Mechanisms (6 papers). Andrew B. McElroy is often cited by papers focused on Neuropeptides and Animal Physiology (7 papers), Asymmetric Synthesis and Catalysis (6 papers) and Protease and Inhibitor Mechanisms (6 papers). Andrew B. McElroy collaborates with scholars based in United Kingdom, United States and Netherlands. Andrew B. McElroy's co-authors include Gerard M. McGeehan, Stuart Warren, James G. Conway, Les Sekut, David H. Drewry, James Nichols, Brian Champion, Stephen E. Karp, Paul J. Furdon and Frank J. Schoenen and has published in prestigious journals such as Nature, Science and The Journal of Experimental Medicine.

In The Last Decade

Andrew B. McElroy

37 papers receiving 1.3k citations

Peers

Andrew B. McElroy

ONCOL

HEMAT

Alan H. Davidson United Kingdom

Matthew J. Taylor United States

Shahin Emami France

Gerard M. McGeehan United States

Dalia Seger Israel

Philipp F. Lange Canada

Thomas J. Owen United Kingdom

Gary J. Williams United States

Bryan Knuckley United States

Xiangao Sun United States

Alan H. Davidson United Kingdom

Andrew B. McElroy

588 ×1.0

606 ×1.3

448 ×1.1

ONCOL

334 ×1.3

239 ×1.2

HEMAT

Citations per year, relative to Andrew B. McElroy Andrew B. McElroy (= 1×) peers Alan H. Davidson

Countries citing papers authored by Andrew B. McElroy

Since Specialization

Citations

This map shows the geographic impact of Andrew B. McElroy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew B. McElroy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew B. McElroy more than expected).

Fields of papers citing papers by Andrew B. McElroy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew B. McElroy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew B. McElroy. The network helps show where Andrew B. McElroy may publish in the future.

Co-authorship network of co-authors of Andrew B. McElroy

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew B. McElroy. A scholar is included among the top collaborators of Andrew B. McElroy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew B. McElroy. Andrew B. McElroy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bartelink, Imke H., Pierre M. Bet, Nienke van Rein, et al.. (2022). The INVENT COVID trial: a structured protocol for a randomized controlled trial investigating the efficacy and safety of intravenous imatinib mesylate (Impentri®) in subjects with acute respiratory distress syndrome induced by COVID-19. Trials. 23(1). 158–158. 7 indexed citations

Bailey, Simon, Paul V. Fish, Jon Bordner, et al.. (2008). Succinyl hydroxamates as potent and selective non-peptidic inhibitors of procollagen C-proteinase: Design, synthesis, and evaluation as topically applied, dermal anti-scarring agents. Bioorganic & Medicinal Chemistry Letters. 18(24). 6562–6567. 19 indexed citations

Fish, Paul V., Simon Bailey, Julian Blagg, et al.. (2007). Potent and Selective Nonpeptidic Inhibitors of Procollagen C-Proteinase. Journal of Medicinal Chemistry. 50(15). 3442–3456. 55 indexed citations

Snaith, J. S., Richard F. W. Jackson, Andrew B. McElroy, et al.. (2002). Synthesis of Macrocyclic, Potential Protease Inhibitors Using a Generic Scaffold. The Journal of Organic Chemistry. 67(14). 4882–4892. 29 indexed citations

Smith, Paul W., Anthony W. J. Cooper, Richard L. Bell, et al.. (1995). New Spiropiperidines as Potent and Selective Non-Peptide Tachykinin NK2 Receptor Antagonists. Journal of Medicinal Chemistry. 38(19). 3772–3779. 18 indexed citations

Conway, James G., Roger H. Brown, Brian E. Marron, et al.. (1995). Inhibition of cartilage and bone destruction in adjuvant arthritis in the rat by a matrix metalloproteinase inhibitor.. The Journal of Experimental Medicine. 182(2). 449–457. 86 indexed citations

Clayden, Jonathan, Andrew B. McElroy, & Stuart Warren. (1995). Control over absolute (R,S), relative (syn,anti) and geometrical (E,Z) stereochemistry in the synthesis of allylically substituted alkenes from diphenylphosphinoyl epoxy alcohols. Journal of the Chemical Society Perkin Transactions 1. 1913–1913. 12 indexed citations

McGeehan, Gerard M., J. David Becherer, Robert C. Bast, et al.. (1994). Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor. Nature. 370(6490). 558–561. 485 indexed citations

Brown, Frank K., Peter J. Brown, D. Mark Bickett, et al.. (1994). Matrix Metalloproteinase Inhibitors Containing a [(Carboxyalkyl)amino]zinc Ligand: Modification of the P1 and P2' Residues. Journal of Medicinal Chemistry. 37(5). 674–688. 38 indexed citations

10.

Cooper, Anthony W. J., Richard L. Bell, Andrew B. McElroy, et al.. (1994). GR159897 and related analogues as highly potent, orally active non-peptide neurokinin NK2 receptor antagonists.. Bioorganic & Medicinal Chemistry Letters. 4(16). 1951–1956. 14 indexed citations

11.

Hagan, R.M., I.J.M. Beresford, Jenny Stables, et al.. (1993). Characterisation, CNS distribution and function of NK2 receptors studied using potent NK2 receptor antagonists. Regulatory Peptides. 46(1-2). 9–19. 50 indexed citations

12.

McElroy, Andrew B.. (1993). Patent Update: Neurokinin Receptor Antagonists. 3(8). 1157–1172. 3 indexed citations

13.

SCOPES, D. I. C., D. Neil Hayes, David Belton, et al.. (1992). New .kappa.-receptor agonists based upon a 2-[(alkylamino)methyl]piperidine nucleus. Journal of Medicinal Chemistry. 35(3). 490–501. 18 indexed citations

14.

Deal, Martyn J., Russell M. Hagan, S.J. Ireland, et al.. (1992). Conformationally constrained tachykinin analogs: potent and highly selective neurokinin NK-2 receptor agonists. Journal of Medicinal Chemistry. 35(22). 4195–4204. 26 indexed citations

15.

McElroy, Andrew B., Martyn J. Deal, Russell M. Hagan, et al.. (1992). Highly potent and selective heptapeptide antagonists of the neurokinin NK-2 receptor. Journal of Medicinal Chemistry. 35(14). 2582–2591. 62 indexed citations

16.

Judd, Duncan B., Dearg S. Brown, Andrew B. McElroy, et al.. (1992). Synthesis, antinociceptive activity and opioid receptor profiles of substituted trans-3-(decahydro- and octahydro-4a-isoquinolinyl)phenols. Journal of Medicinal Chemistry. 35(1). 48–56. 5 indexed citations

17.

Pietra, Claudio, et al.. (1992). Effect of selective antagonists at tachykinin NK-1 and NK-2 receptors on xylene-induced cystitis in rats. Neuropeptides. 22(1). 52–52. 18 indexed citations

18.

McElroy, Andrew B., et al.. (1990). Synthesis, antinociceptive activity, and opioid receptor profiles of 10-substituted-6-oxamorphinans. Journal of the Chemical Society Perkin Transactions 1. 1563–1563. 4 indexed citations

19.

Brown, Dearg S., Andrew B. McElroy, D. I. C. SCOPES, et al.. (1989). Synthesis, antinociceptive activity and opioid receptor profiles of trans-3-(octahydro-2H-pyrano[2,3-c]pyridin-4a-yl)phenols and trans-3-(octahydro-1H-pyrano[3,4-c]pyridin-4a-yl)phenols. Journal of the Chemical Society Perkin Transactions 1. 1187–1187. 4 indexed citations

20.

Elliott, Jason, et al.. (1985). A regiospecific route to conjugated enones viaα-phenylthio ketones. Journal of the Chemical Society Perkin Transactions 1. 1237–1244. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact